Redona Therapeutics

Redona Therapeutics focuses on developing RNA-based therapies aimed at treating cancer and various human diseases. The company researches short non-coding RNAs that inhibit gene expression by suppressing mRNA translation and promoting mRNA decay. By targeting RNA modulating proteins with small molecules, Redona Therapeutics seeks to adjust the expression levels of oncogenes and other significant proteins involved in disease processes. This innovative approach enables health professionals to specifically target microRNAs that play critical roles in cancer initiation, progression, and metastasis, offering potential new avenues for therapeutic intervention.